News

We are honored to announce Robinson Ventures’ first investment of 2024: Vivifi Medical!

 

 

Vivifi is revolutionizing the field of medical technologies. Their mission is to improve the quality of life for patients with Benign Prostate Hyperplasia (BPH) and infertility. They were named the FDA Track winner for the 2023 Startup Prize: Focus on Health!

Varicocele affects approximately 30 million men in the US alone and is the direct cause of over 1.5 million infertile couples. Vivifi has developed the Calexis-Lap device, the world’s first suture-less, minimally invasive solution for immediate and long-lasting reversal of varicocele. They’re currently working on developing a medically relevant prototype of their laparoscopic device and hope to enter the testing phases soon!

Vivifi made a lot of progress in the first quarter of 2024, adding 4 new highly qualified specialists to their team, as well as several exceptional advisors. They aren’t done yet, though, and we look forward to future progress!

You can reach out to Vivifi through their website: https://www.vivifimedical.com/